PE-Backed Choice Health at Home Bolsters Oklahoma Footprint With Accentra Home Health and Hospice

PE-Backed Choice Health at Home Bolsters Oklahoma Footprint With Accentra Home Health and Hospice

Private equity-backed Choice Health at Home announced that it is acquiring the Oklahoma City-based Accentra Home Health and Hospice. Accentra Home Health and Hospice is dedicated to providing home health and hospice services to patients across Oklahoma. Accenture’s growing network can admit patients in the cities and towns surrounding Oklahoma City, Tulsa, Kingfisher, Henryetta, Norman, Duncan, Chickasha and Enid. Choice Health at Home, a portfolio company of Coltala Holdings and backed by Trive Capital, was founded in 2008 as a rehabilitation service provider, entered home health in late 2012 and launched its hospice segment in 2018. The company provides a broad spectrum of... Read More »
Cencora Picks Up Texas-Based MSO Platform Retina Consultants of America

Cencora Picks Up Texas-Based MSO Platform Retina Consultants of America

Cencora, Inc. announced on November 6 that it has entered into a definitive agreement to acquire Retina Consultants of America (RCA) from Webster Equity Partners. Cencora will acquire RCA for approximately $4.6 billion in cash, subject to a customary working capital and net debt adjustment. RCA is a new specialty platform created by the acquisition and merger of Retina Consultants of Houston, Retina Group of Florida, Long Island Vitreoretinal Consultants and Retinal Consultants (Northern California). RCA is a Southlake, Texas-based management services organization (MSO) of retina specialists. Cencora, formerly known as AmerisourceBergen, is an American drug wholesale company and a contract... Read More »
Behind the Deal: Agenda Health Advises Angels Crossing Home Hospice in Sale to Mission Health Services

Behind the Deal: Agenda Health Advises Angels Crossing Home Hospice in Sale to Mission Health Services

Agenda Health, a healthcare-focused M&A advisory firm, recently played a key role in the acquisition of Angels Crossing Home Hospice, a Utah-based hospice provider, by Mission Health Services. This strategic acquisition allows Mission Health Services to enhance its hospice care offerings within Utah. Angels Crossing Home Hospice, headquartered in Midvale, Utah, focuses on bringing meaning and fulfillment during the final stage of life, in addition to providing comfort and symptom management related to a patient’s illness. Mission Health Services, also based in Utah and founded in 1990, is a non-profit organization offering skilled nursing, rehabilitation, assisted living, memory care... Read More »
CoachCare Buys California-Based RPM Company Dedica Health

CoachCare Buys California-Based RPM Company Dedica Health

CoachCare ended October 2024 with an acquisition announcement. The company announced on October 29 that it acquired Dedica Health for an undisclosed amount. Dedica Health is a California-based remote patient monitoring (RPM) company, with expertise in primary care and cardiology. The Dedica Health app monitors patient data from connected devices between office visits. CoachCare is a New-York based RPM and virtual health company. More than 150,000 patients in 3,000 locations benefit from CoachCare’s suite of virtual tools, including remote patient monitoring, video conferencing, real-time messaging, screening, content sharing and connected devices. The two digital health companies have... Read More »
Headlands Research Acquires Trial Management Associates

Headlands Research Acquires Trial Management Associates

Headlands Research has announced the acquisition of Trial Management Associates (TMA). The addition of TMA extends Headlands Research’s southeastern U.S. geographical reach. The Headlands Research network now includes 21 sites across the United States and Canada. Financial terms of the deal were not disclosed. TMA is a multi-site clinical research company with locations in North and South Carolina. The company is headquartered in Wilmington, North Carolina, with an additional location in Myrtle Beach, South Carolina. TMA brings experience across various therapeutic specialties, including vaccines, endocrinology and more. Headlands Research, a portfolio company of KKR & Co., is a... Read More »
Elevate Patient Financial Buys RCM Provider NYX Health Eligibility Services 

Elevate Patient Financial Buys RCM Provider NYX Health Eligibility Services 

Elevate Patient Financial Solutions announced on November 5 the acquisition of NYX Health Eligibility Services for an undisclosed price. NYX Health Eligibility Services provides revenue cycle management (RCM) solutions focused on Medicaid eligibility verification and enrollment on behalf of hospitals and health systems. NYX Health Eligibility Services was founded in 2023 and is based in Alpharetta, Georgia. Elevate Patient Financial Solutions delivers RCM solutions to hospitals, health systems and health providers nationwide. ElevatePFS is backed by private equity firms Frazier Healthcare Partners and The Edgewater Funds. This acquisition strengthens Elevate’s current eligibility and... Read More »
Earnings Week in Review: Navigating Challenges and Growth in Q3 2024 Healthcare

Earnings Week in Review: Navigating Challenges and Growth in Q3 2024 Healthcare

We’re taking a look at some of the major companies reporting earnings in the week of October 28 – November 1, across a variety of sectors. Managed Care providers Humana and Cigna reported significant growth, driven by their health insurance offerings. The eHealth space saw Teladoc Health and American Well Corp. navigating competitive pressures and market shifts, highlighting the dynamic nature of digital health. Meanwhile, Stryker Corp.’s strong earnings performance in the Medical Devices segment contrasted with Avanos Medical’s struggle with cost pressures. These earnings reports offer a comprehensive view of the healthcare industry’s current performance and future... Read More »
DRI Healthcare Trust Acquires Interest in KalVista Pharmaceuticals’ Sebetralstat for $100 Million 

DRI Healthcare Trust Acquires Interest in KalVista Pharmaceuticals’ Sebetralstat for $100 Million 

On November 4, DRI Healthcare Trust announced that it acquired the royalty interest in Sebetralstat, a novel investigational candidate for the oral, on-demand treatment of hereditary angioedema from KalVista Pharmaceuticals, Inc.  Sebetralstat is under regulatory review by the FDA with a Prescription Drug User Fee Act goal date of June 17, 2025. KalVista Pharmaceuticals, Inc. is a global pharmaceutical company.  DRI Healthcare Trust is a healthcare royalty investment company based in Toronto. The company is managed by DRI Capital, a Canadian healthcare royalty private equity firm. Since its initial public offering in 2021, DRI has deployed more than $1 billion, acquiring more... Read More »
OrthoIndy and Indiana Hand to Shoulder Center Announce Merger 

OrthoIndy and Indiana Hand to Shoulder Center Announce Merger 

On October 30, OrthoIndy announced that it was purchasing Indiana Hand to Shoulder Center for an undisclosed amount.   Indiana Hand to Shoulder Center is an orthopedic practice with 10 locations across Indiana. According to its website, there are 12 physicians on staff.  OrthoIndy is an orthopedic practice based in Indiana. With more than 85 physicians on staff, the practice operates out of 13 locations across the state.   “This alignment works to ensure that we will continue to serve the community’s orthopedic needs as an independent physician practice, which we believe is vital to Indiana’s healthcare ecosystem,” said John Ryan, CEO of OrthoIndy. “In a world... Read More »
The Current State of the Healthcare Investment Market: Insights from the McGuireWoods Healthcare Finance and Growth Conference

The Current State of the Healthcare Investment Market: Insights from the McGuireWoods Healthcare Finance and Growth Conference

McGuireWoods’ 17th Annual Healthcare Finance and Growth Conference brought together more than 200 healthcare leaders to explore the latest developments and challenges shaping the industry in 2024 and beyond. Through a combination of in-depth panels and engaging networking sessions, attendees had the opportunity to connect with industry peers and gain insights into emerging trends and sectors, from the future of telehealth to the evolving role of value-based care in driving healthcare outcomes. With 15 panels and 57 speakers, the conference covered a wide array of topics, offering actionable strategies for navigating the current and evolving healthcare investment market landscape. On day... Read More »